Paper Details

  1. Home
  2. Paper Details

Profile of mirabegron in the treatment of overactive bladder: place in therapy.

Author: HashimHashim, SharafAla'a

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Mirabegron is a new drug for treating overactive bladder syndrome. It can be used alone or in combination with other treatments. Studies have shown that mirabegron is effective and well-tolerated, but some potential side effects are of concern. This review summarizes the clinical trials on mirabegron, its pharmacokinetics, mechanism of action, and side effects.
Paper Details　
Original Abstract of the Article :
Mirabegron is a relatively new drug introduced to treat overactive bladder syndrome. It can be used either on its own or as part of a combination. This drug has been extensively studied, with a good number of Phase II and Phase III trials showing promising outcomes. These studies show that mirabegro...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325094/

データ提供：米国国立医学図書館（NLM）

Mirabegron: A New Hope for Overactive Bladder

Overactive bladder (OAB) is a common and often embarrassing condition, affecting millions worldwide. This research explores the potential of mirabegron, a new medication for OAB, highlighting its efficacy and safety profile. It's like discovering a new oasis in the vast desert of OAB research, offering a potential solution to this debilitating condition.

Mirabegron: A Promising Treatment for OAB

The study reveals that mirabegron, a beta-3 adrenergic receptor agonist, shows promise in treating OAB. It's like finding a hidden well of fresh water in the desert, providing relief from the symptoms of OAB. The research underscores the need for careful consideration of potential adverse effects but highlights the potential of this medication as a valuable treatment option.

Implications for OAB Management

This research offers a ray of hope in the desert of OAB treatment. It's like a map guiding us toward a more effective management strategy for this common condition. The study's findings can help physicians make informed decisions about treatment options, potentially improving the quality of life for millions of people suffering from OAB.

Dr.Camel's Conclusion

This research is like a cool breeze in the desert of OAB, offering a new and potentially effective treatment option for this widespread condition. Mirabegron shows promise as a valuable tool for managing OAB, bringing relief and improving quality of life. This research reminds us that the pursuit of new treatments for common conditions is a vital journey, one that can lead to significant improvements in human health and well-being.

Date :
  1. Date Completed 2017-05-15
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

28255232

DOI: Digital Object Identifier

PMC5325094

Related Literature

Article Analysis
・Side Effects of mirabegron
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.